IL1B and urinary bladder cancer: With the recombinant IL-1β (Invitrogen, Waltham, MS, USA) added into the culture medium of MB49 cells for determining the potential impact on survival of bladder cancer cells, clonogenic survival in irradiated bladder cancer cells was reduced with the added IL-1β protein in a dose-dependent manner (Figure S6).